Alok Ranjan
Postdoc at National Institute of Health (NIH)/ National Cancer Institute (NCI), Clinical Center, Bethesda
Dr. Ranjan first became interested in cancer research after completing his undergraduate degree from India in 2010. ?I was fascinated by the power of cancer and how normal cells of the body overcome the death cycle to become cancerous.? Originally from India, Dr. Ranjan moved to the United States in 2012 to pursue graduate opportunities in cancer research at Texas Tech University Health Sciences Center, TX During his graduate study, he served as Chair and Vice-President of American Association of Pharmaceutical Scientists students? chapter for Texas Tech University, Amarillo. Dr. Ranjan?s doctoral research on cancer and metastasis earned him several prestigious awards including Scholar-In-Training Award at American Association for Cancer Research (AACR) and Graduate Student Research Award in Biotechnology at American Association of Pharmaceutical Scientists (AAPS) annual meetings. He defended his dissertation in December 2016 and was awarded with Outstanding Graduate Student of the Year award. He has over five years of research experience in immuno-oncology, mouse tumor models, cancer biology, molecular biology, cancer signaling, and translational studies using cell-based assays and basic molecular biology techniques. Dr. Ranjan accomplished Ph.D. with multiple first author publications in peer-reviewed journals, awards and research grants as a primary investigator. Currently, working at National Institute of Health (NIH)/ National Cancer Institute (NCI), Clinical Center, Bethesda, MD as postdoctoral fellow.
Highly interested in oncology, immuno-oncology studies and In vivo tumor models. Investigating the roles of genes as being the regulators of the metastasis cascade and reactivation of dormant cancer cells to gives metastatic outgrowth in cancer patients.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 